Detalhe da pesquisa
1.
Using What We Already Have: Uncovering New Drug Repurposing Strategies in Existing Omics Data.
Annu Rev Pharmacol Toxicol
; 60: 333-352, 2020 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31337270
2.
Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases.
Front Genet
; 12: 707836, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34394194
3.
Systematically Prioritizing Candidates in Genome-Based Drug Repurposing.
Assay Drug Dev Technol
; 17(8): 352-363, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31769998
4.
Motivation for Launching a Cancer Metastasis Inhibition (CMI) Program.
Target Oncol
; 13(1): 61-68, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29218624
5.
The PathLink Acquired Gestational Tissue Bank: Feasibility of Project PLACENTA.
J Reprod Biotechnol Fertil
; 7: 14-27, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30637122
6.
When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data.
Assay Drug Dev Technol
; 15(8): 354-361, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29193979
7.
Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics.
Assay Drug Dev Technol
; 15(3): 113-119, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28379727
8.
Advocating for mutually beneficial access to shelved compounds.
Future Med Chem
; 10(12): 1395-1398, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29788759